Cardiology Associates of North Mississippi

What Cardiology Associates of North Mississippi does

Cardiology Associates of North Mississippi (CANM) is a private, single-specialty cardiology practice structured as a Professional Association (P.A.), headquartered in Tupelo, Mississippi. Founded in 1976, the practice operates five clinic locations across North Mississippi (Tupelo, Starkville, Oxford, Columbus, Corinth) and delivers comprehensive cardiovascular care including diagnostic testing, interventional procedures, electrophysiology, device management, and clinical research. The clinical team comprises 20 practitioners covering general invasive cardiology, interventional cardiology, and electrophysiology, supported by nurse practitioners and a Pharm.D. specializing in cardiovascular risk management. Ancillary programs include specialty clinics for atrial fibrillation, hypertrophic cardiomyopathy, peripheral vascular disease, lipid disorders, anti-coagulation, and preventative care, with advanced capabilities including cardiac PET scanning with Rubidium-82, intracoronary ultrasound, and remote digital monitoring of pacemakers and implantable defibrillators for over 1,000 device patients.

The practice operates a Clinical Research Program established in 1997 that has completed over 225 trials (Phase II-IV IND drug studies, IDE trials for stents, pacemakers, defibrillators, and heart failure devices) and enrolled more than 3,000 patients from 25 surrounding counties. The research program has produced 20+ publications in top-tier journals including NEJM, JAMA, and JACC, and is recognized as a top-enrolling center nationally and internationally for 25+ trials. The practice accepts a wide range of insurance including Medicare, Mississippi Medicaid, Blue Cross Blue Shield of Mississippi, Cigna, Humana ChoiceCare, United Healthcare, Tricare, and HealthLink, with revenue generated from insurance-billed clinical services and professional services revenue from clinical research, including a separate Cardiology Associates Research, LLC entity.

The go-to-market model is primarily physician referral-driven, supported by CANM Referral Direct (a web-enabled referral system for ordering diagnostic tests) and supplemented by outbound patient engagement through the website, MyChart patient portal, and a Facebook page. Cardiology Associates of North Mississippi is physician-owned with no parent company, no private equity or venture capital ownership, and no public funding rounds. The practice maintains formal research partnerships with major cardiovascular industry players including Boston Scientific, Medtronic, Abbott Vascular, Biotronik, St. Jude Medical, Shockwave Medical, Johnson & Johnson, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, Esperion Therapeutics, Amgen, Novartis, Boehringer Ingelheim, Sanofi-Aventis, Merck, and American Regent.

Name

Cardiology Associates of North Mississippi

Legal name

Cardiology Associates of North Mississippi, P.A.

Website

https://canm.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

101–250 employees

Short description

Cardiology Associates of North Mississippi is a private multi-clinic cardiology practice providing comprehensive cardiovascular care, interventional procedures, and clinical research across five locations in North Mississippi, serving patients from 25 surrounding counties.

Ownership category

akta.pro rank

Product category

Cardiology Medical Services

NAICS

Offices of Physicians (62111), Offices of Physicians (except Mental Health Specialists) (621111), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

General Cardiology (Consultative) (HLAKABAA)

akta.pro secondary industries

Interventional Cardiology (PCI/Structural Heart) (HLAKABAB), Electrophysiology (Heart Rhythm) (HLAKABAC), Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based) (HLAFABAK), Cardiac Diagnostic Centers (Echo/Stress Testing/Holter) (HLAFAKAE), Cardiovascular / Cath Lab & Electrophysiology Centers (HLAFAIAI)

Keywords

• Cardiology medical practice
• Cardiac diagnostic testing
• Interventional cardiology services
• Electrophysiology and devices
• Cardiology clinical research

Headquarters

HQ city

Tupelo

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Clinical Services Revenue: Revenue generated from consultation, diagnostic testing, interventional procedures, and ongoing patient care across five clinic locations in Mississippi. Services are billed to insurance providers including Medicare, Medicaid, and commercial carriers.
2. Clinical Research Program: Revenue from participation in clinical trials. Most items needed by research studies are provided at no cost to the patient or their insurance, including follow-up visits. Study medications/treatments are provided at no cost. Services not related to research are billed to insurance. Cardiology Associates Research, LLC operates as a distinct entity within the practice.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Cardiology Associates of North Mississippi is a single-specialty cardiology medical practice delivering comprehensive cardiovascular care, including diagnostic testing, interventional procedures, electrophysiology, device management, and specialty programs (lipid, anticoagulation, atrial fibrillation, hypertrophic cardiomyopathy, peripheral vascular disease, preventative care, and heart failure therapy). It supplements clinical care with a long-standing Clinical Research Program conducting Phase II-IV drug studies and IDE device trials, and operates the CANM Referral Direct online physician referral system across five clinic locations.

Product overview

Cardiology Associates of North Mississippi (CANM) is a cardiology subspecialty practice operating as a single-specialty medical group rather than a unified software platform. The practice offers a comprehensive portfolio of cardiovascular services organized into distinct programs: Diagnostic Testing (EKG, echocardiogram, stress tests, cardiac catheterization, MRI, nuclear imaging, PET, CT angiography, ultrasound), Interventional Procedures (angioplasty, stenting, atherectomy, bypass surgery), Electrophysiology Services (ablation, pacemaker/ICD management), and Specialty Programs (Device Management for 1,000+ patients with pacemakers/ICDs, Peripheral Vascular Disease, Lipid, Anti-Coagulation, Atrial Fibrillation, Hypertrophic Cardiomyopathy, Preventative Care, and Congestive Heart Failure Therapy). The practice also operates a Clinical Research Program established in 1997 that has conducted over 225 trials. Services are delivered across five clinic locations in Tupelo, Starkville, Oxford, Columbus, and Corinth, Mississippi, with affiliated hospital privileges. The practice accepts multiple insurance plans including Blue Cross Blue Shield of Mississippi, Cigna, HealthLink, Humana, Medicare, Mississippi Medicaid, United Healthcare, and Tricare.

Differentiator

Problem solved

Functional benefit

Products and services

• Diagnostic Tests Comprehensive cardiovascular diagnostic testing services including electrocardiogram (EKG/ECG), echocardiogram, stress tests, cardiac catheterization, cardiac MRI, nuclear stress tests, transesophageal echocardiogram (TEE), tilt-table tests, arrhythmia monitoring, angiograms (renal, peripheral, carotid), duplex ultrasound, intracoronary ultrasound, cardiac CTA/calcium score, and cardiac PET imaging. For patients with suspected or known heart disease.
• Interventional Procedures Minimally invasive catheter-based interventional procedures including angioplasty, stenting, atherectomy, thrombectomy, coronary bypass surgery, embolization, atrial septal defect closure, carotid stenting, and pacemaker/ICD implantation. For patients with coronary artery disease, structural heart conditions, and vascular disease.
• Electrophysiology Services Cardiac electrophysiology studies and treatments including radiofrequency ablation, atrial fibrillation ablation, anti-arrhythmic therapy, and pacemaker/ICD management. For patients with arrhythmias and rhythm disorders.
• Cardiac Rehabilitation Oversight of cardiac rehabilitation programs designed to help patients recover from heart-related events such as heart attacks or cardiac surgeries, involving exercise training, education on heart-healthy behaviors, and emotional support. For post-event cardiac patients.
• Medication Management Prescription and management of medications for heart-related conditions including hypertension, arrhythmias, heart failure, high cholesterol, lipid reduction therapy, anti-coagulant therapy, and anti-anginal therapy. For patients with chronic cardiovascular conditions.
• Lifestyle Counseling Guidance on adopting heart-healthy lifestyle habits including regular exercise, maintaining a healthy diet, quitting smoking, and managing stress. For patients seeking cardiovascular risk reduction and prevention.
• Device Program Specialty device management program following more than 1,000 patients with pacemakers and/or implantable cardioverter defibrillators (ICDs) across four clinic locations, including remote digital monitoring capabilities for testing devices from patients' homes. For patients with implanted cardiac devices.
• Peripheral Vascular Disease (PVD) Program Comprehensive diagnosis, testing, and treatment of peripheral vascular disease affecting blood flow to arms, kidneys, brain, and legs, including ABI testing, CTA, and duplex imaging. For patients with suspected or known peripheral vascular disease.
• Lipid Program Management of difficult-to-manage dyslipidemia with medication, dietary counseling, lifestyle changes, and advanced laboratory testing for complex lipid abnormalities. For patients with complex lipid disorders.
• Anti-Coagulation Program Close monitoring of patients taking anticoagulant medications (such as Coumadin) with three specially trained nurses and a doctor of pharmacy managing the program. For patients on anticoagulation therapy.
• Atrial Fibrillation Program Comprehensive program for education, medical and ablative treatments (AV node ablation, pulmonary isolation), surgical treatments (MAZE), clinical research, and outcome measures for AFib management. For patients with atrial fibrillation.
• Hypertrophic Cardiomyopathy Program Multidisciplinary clinic providing individualized care plans, genotypic analysis, comprehensive evaluation, HOCM family screening, risk stratification for sudden cardiac death, ICD/pacemaker therapy, alcohol septal ablation, and surgical septal myectomy. For patients with hypertrophic cardiomyopathy.
• Preventative Care Program Prevention-focused care including CT calcium score screening, ECG testing, and lipid profile assessments to identify and address cardiovascular risk factors early. For patients seeking cardiovascular risk assessment and prevention.
• Congestive Heart Failure Therapy Treatment for congestive heart failure including addressing underlying causes (coronary artery disease, high blood pressure, diabetes), medications (ACE inhibitors, diuretics, vasodilators, beta-blockers), and consideration of heart transplant. For patients with congestive heart failure.
• Clinical Research Program Established in 1997, the research program has participated in over 225 clinical trials including Phase II-IV IND drug studies, IDE trials for stents, pacemakers, defibrillators, nuclear medicine, and CTA. The program has 9 full-time employees and more than 3,000 patients have participated from 25 counties. Cardiology Associates Research, LLC operates as a distinct entity. Most research-related services and study medications are provided at no cost to patients or insurance. For patients eligible for clinical trials and for pharmaceutical and device trial sponsors.

Quantifiable outcome

• Over 3,000 patients from 25 surrounding counties have participated in clinical research since 1997.
• +3 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

20 partnerships are on record, tiered core and minor.

• Boston ScientificcoreTechnology or IntegrationCardiology Associates has worked with Boston Scientific on coronary stent systems, left atrial appendage closure devices, and cardiac resynchronization therapy (CRT) devices as part of their clinical research program.
• MedtroniccoreTechnology or IntegrationMedtronic collaboration includes CRT devices and renal denervation system for hypertension. Brittany Cook, RN (Research Coordinator) was invited by Medtronic to speak at a national meeting on renal denervation. The ALLEVIATE-HF study utilized the Medtronic LINQ device for heart failure monitoring.
• Abbott VascularcoreTechnology or IntegrationCollaboration on carotid, peripheral and coronary stent systems, and cardiac resynchronization therapy (CRT) devices through clinical trials.
• BiotronikcoreTechnology or IntegrationBiotronik is a medical technology company that collaborated on cardiac resynchronization therapy (CRT) devices. The practice participated in the BIO-CONDUCT trial for LBBAP (left bundle branch area pacing) using Biotronik's Solia S lead and Selectra 3D catheter.
• St. Jude Medical (Abbott)coreTechnology or IntegrationCollaboration on cardiac resynchronization therapy (CRT) devices as part of the clinical research program.
• Shockwave MedicalcoreTechnology or IntegrationCollaboration on intravascular lithotripsy in the peripheral and coronary arteries through clinical trials.
• Johnson & Johnson (Xarelto)coreTechnology or IntegrationParticipated in clinical trials that contributed to bringing Xarelto (rivaroxaban) to market. Part of a broader portfolio of anticoagulant and cardiovascular drug research.
• Bristol-Myers Squibb (Eliquis)coreTechnology or IntegrationParticipated in clinical trials that contributed to bringing Eliquis (apixaban) to market for anticoagulation therapy.
• AstraZeneca (Brilinta, Crestor)coreTechnology or IntegrationClinical trial partner for Brilinta (ticagrelor) and Crestor (rosuvastatin), helping bring these cardiovascular medications to market.
• Eli Lilly & Company (Effient)coreTechnology or IntegrationParticipated in clinical trials that contributed to bringing Effient (prasugrel) to market for antiplatelet therapy.
• Esperion Therapeutics (Nexletol)coreTechnology or IntegrationClinical trial partner for Nexletol (bempedoic acid), a lipid-lowering medication for patients with hypercholesterolemia.
• Amgen (Repatha)coreTechnology or IntegrationParticipated in clinical trials for Repatha (evolocumab), a PCSK9 inhibitor for lipid reduction in cardiovascular disease.
• Novartis (Inclisiran)coreTechnology or IntegrationClinical trial partner for Inclisiran, a novel RNAi therapeutic for LDL cholesterol reduction.
• BMS & Sanofi Pharma (Plavix)coreTechnology or IntegrationParticipated in clinical trials for Plavix (clopidogrel), an antiplatelet agent used to prevent blood clots in cardiovascular disease.
• American Regent (Injectafer)coreTechnology or IntegrationClinical trial partner for Injectafer (ferric carboxymaltose injection), an IV iron replacement therapy for iron deficiency.
• Merck (Zocor)coreTechnology or IntegrationParticipated in clinical trials for Zocor (simvastatin), a statin medication for cholesterol management.
• Boehringer Ingelheim (Pradaxa)coreTechnology or IntegrationClinical trial partner for Pradaxa (dabigatran), a direct thrombin inhibitor anticoagulant.
• Sanofi-Aventis (Multaq)coreTechnology or IntegrationParticipated in clinical trials for Multaq (dronedarone), an antiarrhythmic medication for atrial fibrillation.
• Local Cardiovascular SurgeonscoreStrategic or Co-development PartnerThe research program works in collaboration with local cardiovascular surgeons on clinical trials, providing a multidisciplinary approach to cardiovascular care and research.
• Local Neurology GroupminorStrategic or Co-development PartnerCollaboration with the local neurology group on clinical trials related to shared cardiovascular-neurological conditions such as stroke and carotid artery disease.

Scale indicators8 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Cardiology Associates of Central Florida: Independent single-specialty cardiology group in the southeastern US with comparable subspecialty coverage (general, interventional, EP), multiple clinic locations, and an in-house clinical research program. Closest functional analog to CANM's physician-owned, multi-site private practice model.
• Cardiology Consultants of Philadelphia: Large independent single-specialty cardiology group practice with multiple offices, broad subspecialty coverage, and active participation in clinical trials. Directly comparable as a high-volume, research-active, private cardiology group.

Regional players

• Oklahoma Heart Institute: Regional cardiovascular specialty practice/hospital program serving Oklahoma with comprehensive diagnostic, interventional, and EP services. Comparable in service-line breadth and regional referral-driven model, though operating in a different geography.
• Tennessee Heart (TriStar Health): Regional cardiovascular service line in Tennessee/Mississippi border area with diagnostic, interventional, and EP capabilities. Geographically adjacent to CANM and competes for the same patient population across state lines.

Broad incumbents

• Cardiovascular Associates of America (CVAUSA): PE-backed national platform aggregating independent cardiology practices; offers the most direct counterpoint to CANM by demonstrating the roll-up model and capital-backed competition that an independent P.A. faces. Relevant for partnership/M&A optionality rather than direct patient overlap.
• US Heart & Vascular (USHV): PE-backed cardiology practice platform partnering with independent cardiovascular groups. Comparable in being a cardiology-only consolidator, and relevant as a potential acquirer/partner for an independent group of CANM's scale.
• Sanger Heart & Vascular Institute (Atrium Health): Hospital-integrated cardiovascular service line within a large health system offering the same comprehensive diagnostic, interventional, and EP services as CANM. Illustrates the hospital-employed/integrated model competing with independent cardiology groups for referrals and physicians.
• Cleveland Clinic Heart, Vascular & Thoracic Institute: Top-tier academic cardiovascular program with extensive clinical research output and publications in NEJM/JAMA/JACC. Comparable research footprint and brand prestige, though operating at national-scale academic rather than regional community level.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php?id=100051158931325
• LinkedInlinkedin.com/company/cardiology-associates-of-north-mississippi-p.a.

Revenue estimate

Valuation estimate

Number of profiles

Profiles22 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cardiology Associates of North Mississippi